Here’s What Lifted BrightSpring Health Services (BTSG)

Here’s What Lifted BrightSpring Health Services (BTSG)

Mon, September 21, 2026 at 5:01 PM GMT+3 3 min read

• ^RUT +0.61%
• BTSG -0.09%

Carillon Tower Advisers, an investment management company, released its second-quarter 2026 investor letter for the "Carillon Eagle Small Cap Growth Fund". The letter can be downloaded here. Small-cap stocks rallied broadly in the second quarter, with the Russell 2000 Growth Index (+25.71%) outpacing Value +17.24%). Information Technology (+46.79%) led all sectors, supported by solid gains in Real Estate (+25.91%), Industrials (+25.80%), and Health Care (+25.54%). Consumer and defensive sectors lagged, while Energy (-2.40%) was the sole sector in the red. Following a strong quarter, the outlook for equity markets remains positive, supported by robust corporate profits and economic growth. However, midterm election uncertainties could introduce volatility, especially around data center development, a key economic driver. The $1 trillion data center spending boosts corporate earnings and supports ongoing AI infrastructure investments. Additionally, reviewing the Fund's top five holdings could help identify its best picks for 2026.

In its second-quarter 2026 investor letter, Carillon Eagle Small Cap Growth Fund highlighted BrightSpring Health Services, Inc. (NASDAQ:BTSG). BrightSpring Health Services, Inc. (NASDAQ:BTSG), a US-based home and community-based healthcare services platform operating through Pharmacy Solutions and Provider Services segments, contributed 1.27% to the fund's returns this quarter. On September 18, 2026, BrightSpring Health Services, Inc. (NASDAQ:BTSG) closed at $56.78 per share. Over the past month, BrightSpring Health Services, Inc. (NASDAQ:BTSG) declined 11.23%, but its shares are up 105.72% over the past year. BrightSpring Health Services, Inc. (NASDAQ:BTSG) has a market capitalization of $11.24 billion, and its stock has traded within a 52-week range of $26.28 to $73.75.

Carillon Eagle Small Cap Growth Fund stated the following regarding BrightSpring Health Services, Inc. (NASDAQ:BTSG) in its Q2 2026 investor letter:

"BrightSpring Health Services, Inc. (NASDAQ:BTSG) provides pharmacy distribution and provider services including specialty drug distribution to hospitals, cancer centers, and community oncology practices. The company was a strong contributor as the growth of revenue and earnings before interest, taxes, depreciation, and amortization (EBITDA) exceeded expectations set at its initial public offering (IPO). The company's pharmacy solutions and provider services segments both produced robust total revenue. Pharmacy solutions' success in winning limited-distribution drugs further helped drive growth in adjusted EBITDA and margins."

BrightSpring Health Services, Inc. (NASDAQ:BTSG) is not on our list of the 40 Most Popular Stocks Among Hedge Funds. According to our database, 49 hedge fund portfolios held BrightSpring Health Services, Inc. (NASDAQ:BTSG) at the end of the second quarter, compared to 47 in the previous quarter. While we acknowledge the potential of BrightSpring Health Services, Inc. (NASDAQ:BTSG) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

In addition, please check out our hedge fund investor letters Q2 2026 page for more investor letters from hedge funds and other leading investors.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years.

This article is originally published at Insider Monkey.